In a stunning turn of events, an internal memo from a prominent FDA official has reignited the debate surrounding the COVID-19 vaccines, particularly regarding their potential risks to children. This revelation serves as a significant validation for those who have long questioned the safety of these vaccines, especially when it comes to the youngest and most vulnerable in society.
Dr. Vinay Prasad, the FDA’s Chief Medical and Scientific Officer, has openly acknowledged that COVID-19 vaccines may be linked to at least 10 deaths in children. This revelation came to light through an article by The New York Times, as Dr. Prasad highlighted the dangers of myocarditis—a severe form of heart inflammation—as a possible side effect of the vaccines. He labeled this finding “a profound revelation,” signaling a major shift in the FDA’s approach to vaccine safety and approval processes.
The memo emphasizes the need for comprehensive changes in the way vaccines are tested. Dr. Prasad advocates for mandatory randomized controlled studies for every subgroup prior to authorization. His concerns reflect a desire to prevent the kind of hasty approvals that characterized the pandemic. Such cautious scrutiny is crucial, particularly when the health of children is at stake.
The memo does not specify which vaccines or the health conditions of the affected children were involved, leaving many unanswered questions. Nonetheless, the implications are severe. Upcoming discussions by the CDC’s vaccine advisory committee could lead to more profound discoveries. These deliberations may shape future vaccine policies and communications surrounding their safety.
FDA Commissioner Marty Makary echoed Dr. Prasad’s concerns during a recent Fox News appearance. He stated, “There were, it appears, 10 deaths of children from the COVID shots,” affirming that the data originated from the Biden administration’s time in office. Makary stressed that while COVID-19 vaccines have shown effectiveness in protecting elderly individuals with high-risk factors, the push for annual vaccinations in younger populations is “not based on science.” This sentiment reflects a growing skepticism about the blanket approach to vaccination policies.
This shift in the FDA’s messaging is in line with actions taken by Health and Human Services Secretary Robert F. Kennedy Jr. He has narrowed the recommended COVID vaccine usage to those 65 and older or those with specific health complications, distancing his administration from the previous mandates that required widespread inoculation, including among children.
For years, many parent advocates and independent researchers raised alarms about potential vaccine-related dangers. Often, these voices were dismissed as unreasonable or labeled “conspiracy theorists” by mainstream media and pharmaceutical allies. However, with credible officials like Dr. Prasad and Commissioner Makary acknowledging the risks, the narrative is beginning to shift. The concerns that have simmered for years are now gaining acknowledgment from within health authorities.
This memo has the potential to be a pivotal moment in how vaccines are developed and approved in the future. It signals a critical perspective shift toward greater transparency and accountability in health policy-making. If the emerging truths prompt action to refine testing and approval methods, it could help safeguard against unnecessary tragedies in the years to come.
"*" indicates required fields
